Abstract
The translation of basic behavioral science discoveries into practical strategies represents a promising approach to developing more effective preventive interventions to improve health. Since translational research inevitably involves making use of diverse perspectives from multiple disciplines, it is best conducted as a transdisciplinary enterprise. In this paper, we discuss current strategies used by NIH to support transdisciplinary translational behavioral (TDTB) research, summarize successful efforts, and highlight challenges encountered in conducting such work (ranging from conceptual to organizational to methodological). Using examples from NIH-funded projects we illustrate the potential benefits of, and barriers to, pursuing this type of research and discuss next steps and potential future directions for NIH-supported TDTB research.
Similar content being viewed by others
References
Fishbein DH, Sussman S, Ridenour T, Stahl M. The full translational spectrum of prevention science: facilitating the transfer of knowledge to practices and policies that prevent behavioral health problems, translational behavioral medicine. Transl Behav Med. 2016
Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004; 291(10): 1238-1245.
Schroeder SA. We can do better—Improving the health of the American people. N Engl J Med. 2007; 357: 1221-1228.
Bryan AD, Magnan RM, Nilsson R, Marcus BH, Tompkins SA, Hutchison KE. The big picture of individual differences in physical activity behavior change: a transdisciplinary approach. Psychol Sport Exerc. 2011; 12: 20-26.
PubMed bibliography for Caryn Lerman PhD. Available at: http://www.ncbi.nlm.nih.gov/myncbi/browse/collection/40748322/?sort=date&direction=descending&http%3A%2F%2Fwww.med.upenn.edu%2Fapps%2Ffaculty%2Findex.php%2Fg275%2Fp11960=. Accessibility verified November 4, 2015.
Hall KA, Stokols D, Stipelman BA, et al. Assessing the value of team science: a study comparing center-and investigator-initiated grants. Am J Prev Med. 2012; 42(2): 157-163.
Lerman C, Schnoll RA, Hawk LW, PGRN-PNAT Research Group, et al. Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial. Lancet Respir Med. 2015; 3(2): 131-138.
Lerman C, Gu H, Loughead J, Ruparel K, Yang Y, Stein EA. Large scale brain network coupling predicts acute nicotine abstinence effects on craving and cognitive function. JAMA Psychiatr. 2014; 71(5): 523-530.
Loughead J, Ray R, Wileyto EP, et al. Effects of the α4β2 partial agonist varenicline on brain activity and working memory in abstinent smokers. Biol Psychiatry. 2010; 67(8): 715-721.
Epstein LH, Fletcher KD, O’Neill J, et al. Food characteristics, long-term habituation and energy intake. Laboratory and field studies. Appetite. 2013; 60: 40-50.
Gordon RS. An operational classification of disease prevention. Public Health Rep. 1983; 98(2): 107-109.
National Research Council and Institute of Medicine. Preventing mental, emotional, and behavioral disorders among young people. Washington: National Academies Press; 2009.
Friedman LM, Furberg C, DeMets DL, eds. Fundamentals of clinical trials. New York, NY:Springer Science & Business Media; 2008.
Lipsky MS, Sharp LK. From idea to market: the drug approval process. J Am Board Fam Pract. 2001; 14(5): 362-367.
Rounsaville BJ, Carroll KM, Onken LS. A stage model of behavioral therapies research: getting started and moving on from stage I. Clin Psychol-Sci Pract. 2001; 8: 133-142.
Onken LS, Carroll KM, Shoham V, Cuthbert BN, Riddle M. Reenvisioning clinical science: unifying the discipline to improve the public health. Clin Psychol-Sci Pract. 2014; 2(1): 22-34.
Czajkowski SM, Powell LH, Adler N, et al. From ideas to efficacy: the ORBIT Model for developing behavioral treatments for chronic diseases. Health Psychol. 2015; 34(10):971-982.
Tabak RG, Khoong EC, Chambers DA, Brownson RC. Bridging research and practice: models for dissemination and implementation research. Am J Prev Med. 2012; 43: 337-350.
Greenwald P, Cullen JW. The new emphasis in cancer control. J Natl Cancer Inst. 1985; 74: 543-551.
Flay BR. Efficacy and effectiveness trials (and other phases of research) in the development of health promotion programs. Prev Med. 1986; 15: 451-474.
Committee on the Science of Team Science. Introduction. In: Cooke NJ, Hilton ML, eds. Enhancing the effectiveness of team science. Washington: The National Academies Press; 2015.
Balas E, Boren S. Managing clinical knowledge for health care improvement. In: Bemmel J, McCray AT, eds. Section 1: health and clinical management. In yearbook of medical informatics: patient centered systems. Stuttgart: Schattauer Verlagsgesellschaft; 2000: 65-70.
Westfall JM, Mold J, Fagnan L. Practice-based research—“blue highways” on the NIH roadmap. JAMA. 2007; 297(4): 403-406.
Trochim W, Kane C, Graham MJ, Pincus HA. Evaluating translational research: a process marker model. Clin Transl Sci. 2011; 4(3): 153-162.
Glasgow RE, Emmons KM. How can we increase translation of research into practice? Types of evidence needed. Annu Rev Public Health. 2007; 28: 413-433.
Klesges LM, Estabrooks PA, Dzewaltowski DA, Bull SS, Glasgow RE. Beginning with the application in mind: designing and planning health behavior change interventions to enhance dissemination. Ann Behav Med. 2005; 29(Suppl): 66-75.
Okamoto J, Stipelman BA, Huang G, Hall KL. Comparison and trends in research collaboration: Transdisciplinary Tobacco Use Research Centers co-authorship network properties, 1999–2015. Bethesda, MD: Poster presented at: Sixth Annual International Science of Team Science Conference; 2015
Stipelman BA, Hall KL, Zoss AM, Okamoto J, Stokols D, Borner K. Mapping the impact of transdisciplinary research: a visual comparison of investigator initiated and team based tobacco use research publications. J Transl Med Epidemiol. 2014; 2(2): 10331-10337.
Vogel AL, Stipelman BA, Hall KL, Stokols D, Nebeling L, Spruijt-Metz D. Pioneering the transdisciplinary team science approach: lessons learned from National Cancer Institute grantees. J Transl Med Epidemiol. 2014; 2014; 2(2): 1027, p1-13.
Schully SD, Benedicto CB, Gillanders EM, Wang SS, Khoury MJ. Translational research in cancer genetics: the road less traveled. Public Health Genomics. 2011; 14(1): 1-8.
National Research Counci. Bridging disciplines in the brain, behavioral, and clinical sciences. Washington: The National Academies Press; 2000.
National Research Counci. Enhancing the effectiveness of team science. Washington: The National Academies Press; 2015.
Lei H, Nahum-Shani I, Lynch K, Oslin D, Murphy SA. A “SMART” design for building individualized treatment sequences. Annu Rev Clin Psychol. 2012; 8: 21-48.
Chakraborty B, Collins LM, Strecher V, Murphy SA. Developing multicomponent interventions using fractional factorial designs. Stat Med. 2009; 28: 2687-2708.
Navarro-Barrientos JE, Rivera DE, Collins LM. A dynamical systems model for understanding behavioral interventions and body composition change. Math Comput Model Dyn Syst. 2001; 17(2): 183-203.
Howe GW, Beach SRH, Brody GH. Microtrial methods for translating gene-environment dynamics into preventive interventions. Prev Sci. 2010; 11(4): 343-354.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Compliance with ethical standards
This paper does not involve the use of human subjects or animals. As such, no informed consent was necessary.
Conflict of interest
The authors declare that they have no competing interests.
Additional information
The views expressed in this article are those of the authors and do not necessarily reflect the view of the National Institutes of Health (NIH) or the U.S. Department of Health and Human Services.
Implications
Policy: Funders, reviewers, editors and others who wish to promote and support TDTB research can use the highlighted exemplars funded by NIH to inform the development of structures and systems that better support TDTB research.
Research: Examples provided highlight concrete ways in which TDTB projects, research programs, and initiatives can be designed and implemented at all phases of the translational spectrum.
Practice: Investigators and translational partners engaged in TDTB research can leverage the recommendations proposed in this paper to advance and promote the area of TDTB research.
About this article
Cite this article
Czajkowski, S.M., Lynch, M.R., Hall, K.L. et al. Transdisciplinary translational behavioral (TDTB) research: opportunities, barriers, and innovations. Behav. Med. Pract. Policy Res. 6, 32–43 (2016). https://doi.org/10.1007/s13142-015-0367-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13142-015-0367-3